| Financial Year |
March 31 2023 |
| Monetary Funds |
2,216,374,672.26 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
12,896,792.24 |
| Accounts Receivable |
532,363,642.37 |
| Advances to Suppliers |
26,558,201.20 |
| Other Receivables |
294,204,042.45 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
590,774,952.50 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
30,498,653.59 |
| Total Current Assets |
3,868,524,525.63 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
182,208,471.66 |
| Investment Properties |
-- |
| Fixed Assetes |
1,404,711,951.76 |
| Under-construction Projects |
639,360,362.81 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
155,576,888.30 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,577,812.83 |
| Deferred Income Tax Assets |
67,433,439.25 |
| Other Non-Current Assets |
30,533,629.52 |
| Sub-Total of Non-Current Assets |
2,513,480,243.25 |
| Total Assets |
6,382,004,768.88 |
| Short-Term Loans |
66,648,261.66 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
84,761,834.23 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
18,480,593.97 |
| Taxes Payable |
183,496,939.30 |
| Interest Payable |
44,069,220.59 |
| Dividend Payable |
-- |
| Other payables |
809,144,092.08 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
50,544,469.61 |
| Other Current Liabilities |
13,595,803.81 |
| Sub-Total of Current Liabilities |
1,286,007,197.71 |
| Long-term Loans |
63,342,056.98 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
20,956,609.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
206,263,903.31 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
452,433,403.19 |
| Total Liabilities |
1,738,440,600.90 |
| Paid-In Capital(Or Share Stock) |
253,556,828.00 |
| Capital Surplus |
4,909,386,529.52 |
| Surplus Reserve |
211,879,937.60 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-824,598,306.07 |
| Minority Stockholder's Interest |
81,477,543.15 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,562,086,624.83 |
| Owner's Equity（Stockholder's Equity） |
4,643,564,167.98 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,382,004,768.88 |
